Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Northwestern Alumni Return to Share Insight Into Industry
Campus News

Northwestern Alumni Return to Share Insight Into Industry

By Will DossOct 11, 2017
Share
Facebook Twitter Email
bauer
Eugene Bauer, ’67 MD, detailed his experiences as a pharmaceutical company founder and executive.

The inaugural session of the “MDs in Business” seminar series, organized by the Northwestern Medical Alumni Association Board, featured two Feinberg alumni discussing the lessons they learned working in the pharmaceutical industry.

The seminar featured Eugene Bauer, ’67 MD, founder and chief medical officer of Dermira Inc., and Bruce Scharschmidt, ’70 MD, currently an independent consultant to biotechnology companies and previously the senior vice president and chief medical and development officer at Hyperion Therapeutics.

Bauer said that the relationship between academia and industry has changed drastically over the years.

“Partnership between academia and industry meant industry got more access to discoveries, which gave them a better return on investment than if they had to build up the research enterprise internally,” Bauer said. “At the same time, academic institutions got essential money to upgrade and build academic infrastructure.”

A product he worked on that failed to reach the market taught Bauer a valuable lesson, he said.

“When you’re working on ideas, expect to fail,” Bauer said. “Have a tolerance for it — have a plan A, and if that doesn’t work have a plan B, and if that doesn’t work have a plan C.”

schar
Bruce Scharschmidt, ’70 MD, shared experiences from his time in the pharmaceutical industry as part of Feinberg’s “MDs in Business” seminar series.

Scharschmidt echoed these thoughts, focusing on the stark differences between life as an academic physician and life as a pharmaceutical entrepreneur.

MDs in industry, Scharschmidt said, can have a much different experience than in academia — products often fail, and even a successful product can take years or decades to come to market. He also stressed the importance of getting to the point. Physicians are taught to establish trust and warmth, but there isn’t always time for those niceties in meetings with hedge fund managers or investors.

“Make sure the first one or two sentences out of your mouth telegraph the message,” Scharschmidt said. “You can backfill the details if time permits.”

Both speakers said they were thankful to Northwestern for giving them the tools to succeed in clinical practice and private industry alike.

“I’m grateful to NU because it enabled me to think about my careers in medicine and industry in ways that were flexible,” Bauer said.

“My education and experience as a practicing physician gave me valuable perspective, which I was able to bring to the table in industry,” Scharschmidt added.

The next iteration of “MDs in Business” is tentatively scheduled for early 2018, with more Northwestern alumni taking part: Jeff Sherman, MD, ’84 GME, chief medical officer of Horizon Pharmaceuticals, and Jordan Dubow, ’03 MD, ’07 GME, a pharmaceutical consultant who specializes in designing clinical trials.

The seminar series is meant to highlight entrepreneurs with a Feinberg pedigree, to give students, residents and fellows a window into corporate career paths, according to Jeffrey Masters, PhD, Northwestern Medicine senior director of corporate relations.

“We want to tell students where to go if they are interested in getting involved in clinical trials, for example,” Masters said. “Or, if they are more entrepreneurial; how do you go about getting money, how do you launch an IP — these are the questions we want to answer.”

Alumni Events
Share. Facebook Twitter Email

Related Posts

McNally Honored with Walder Award

Jun 8, 2023

Discussing New Frontiers in Biomedicine

Jun 1, 2023

Northwestern Accepting Nominations for $350,000 Nemmers Prize in Medical Science

May 30, 2023

Comments are closed.

Latest News

Coaxing Hair Growth in Aging Hair Follicle Stem Cells

Jun 9, 2023

New Therapeutic Target for Osteoarthritis Identified 

Jun 9, 2023

Largest Cell Map of Human Lung Reveals Insights Into Disease

Jun 8, 2023

McNally Honored with Walder Award

Jun 8, 2023

Biological Aging Increases Risk of Depression, Anxiety in Adults 

Jun 7, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
ANB05555
ANB08990
ANB09022
ANB09063
ANB09008
ANB08781
ANB08971
ANB09000
ANB08992
ANB09015
ANB09058
ANB09048

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.